Genzyme continued to drive growth for Sanofi in the first quarter, helped along by the company’s vaccines unit, but diabetes drugs are still struggling. Net sales were €8,391 million, an ...

Sanofi is reorganising its business units from seven to five in a bid to streamline its operations and ensure the success of its ambitious product launch plans.

See the latest BioMarin Pharmaceutical Inc stock price (BMRN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.